Kinetics in drug discovery
한국시간 : 11월 20일 오전12시
The screening assays employed in drug discovery are abstractions of biological systems, and by their nature are often poorly predictive of efficacy and potency in patients. This is caused, in part, by the use of equilibrium systems to predict patient responses; despite humans being notoriously non-equilibrium in nature. This talk will describe the use and analysis of kinetic methods across the drug discovery journey and their impact for understanding the pharmacology of medicines.
BMG LABTECH will also introduce the key features of the PHERAstar FSX that support binding kinetic assays and key factors for assay optimization to ensure screening success.
많은 참여 부탁드립니다.